Mental Health News

Stay updated on mental health with press releases highlighting trends, treatments, and advocacy efforts addressing mental well-being. Learn about key developments shaping mental health and explore opportunities in psychological research and therapy innovations.

Jun 22, 2026 at 10:00 AM

MetLife Pet Insurance Expands Grief Support for Pet Parents with Memorial Tree Program

NEW YORK--(BUSINESS WIRE)--For many pet parents, saying goodbye to a beloved dog or cat is one of life’s most difficult experiences. MetLife Pet Insurance is introducing a new Memorial Tree Program to help honor that bond, alongside grief counseling services that support pet parents through end-of-life decisions and the months that follow. MetLife Pet Insurance research underscores the depth of that bond: 95% of Americans consider their pet to be family, and 50% say they have grieved a pet’s de...
Jun 22, 2026 at 8:00 AM

Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner

IRVINE, Calif.--(BUSINESS WIRE)--Masimo smartSET™-powered, AI-enabled OIRD detection has received FDA 510(k) clearance for the Radius VSM® wearable continuous patient monitor....
Jun 22, 2026 at 7:00 AM

Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced positive topline results from Emerge, its first randomized, double-blind, placebo-controlled Phase 3 study evaluating a single dose of DT120 (lysergide) ODT 100 µg in adults with major depressive disorder (MDD). Emerge met i...
Jun 21, 2026 at 5:00 PM

Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast tomorrow at 8 a.m. EDT to discuss topline results from Emerge, its first randomized, double-blind, placebo-controlled Phase 3 study evaluating a single dose of DT120 ODT 100 µg in adults with...
Jun 18, 2026 at 9:00 PM

Astrogen Inc. Receives 18th Folia Award for Outstanding Clinical Research in Autism Spectrum Disorder

YOKOHAMA, Japan--(BUSINESS WIRE)--Astrogen, a South Korean biotech company, wins the 18th Folia Award for its autism clinical research, accelerating its expansion into global markets....
Jun 18, 2026 at 12:08 PM

WellSky® Marks Continued Behavioral Health Growth With Expanding Network and Celebrates Success With Partners

OVERLAND PARK, Kan.--(BUSINESS WIRE)--WellSky announced continued behavioral health growth, driven by new and expanded client relationships across the care continuum....
Jun 17, 2026 at 12:30 PM

SimplePractice Launches AI-powered Care Aide to Reduce Administrative Burden and Support Clinical Workflows

LOS ANGELES--(BUSINESS WIRE)--SimplePractice, the leading platform powering independent mental health practitioners, today announced Care Aide, an AI-powered clinical workflow assistant designed to help independent practitioners reduce administrative burden and stay focused on care. Developed with input from more than 1,000 mental health practitioners, Care Aide builds on SimplePractice’s HIPAA-compliant Note Taker and introduces new tools that support clinicians across session preparation, doc...
Jun 17, 2026 at 12:00 PM

Opening of Phoenix Pathways Creates 49 Homes and 42 Shelter Spaces for People in Chilliwack

CHILLIWACK, British Columbia--(BUSINESS WIRE)--People currently unhoused, and others at risk of homelessness, can now access shelter, supportive housing, and enhanced care at Phoenix Pathways, located at 45867 Trethewey Avenue in Chilliwack, B.C. After several years of planning, construction and community engagement, residents, partners, neighbours and Phoenix staff celebrated the opening of the building at the corner of Rowat Avenue and Trethewey Avenue at a community barbecue on June 12, 2026...
Jun 17, 2026 at 10:00 AM

Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) today announced it has invested $640 million in affordable housing over the past five years, building on more than $1 billion invested over nearly two decades. These investments reflect the company’s continued commitment to addressing social drivers of health, helping lower the total cost of care, and expanding access to safe, stable, and affordable housing.Over the past five years, Elevance Health has invested $640 million across 15 pro...
Jun 17, 2026 at 8:00 AM

Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State...
Turn Your News Into Headlines
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up